| Symbol |
Name |
|
AARS
|
alanyl-tRNA synthetase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5
|
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACADM
|
acyl-CoA dehydrogenase, C-4 to C-12 straight chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACSL6
|
acyl-CoA synthetase long-chain family member 6
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTG1
|
actin gamma 1
|
|
ACTN2
|
actinin, alpha 2
|
|
ACVR1
|
activin A receptor, type I
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS18
|
ADAM metallopeptidase with thrombospondin type 1 motif, 18
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK2
|
adrenergic, beta, receptor kinase 2
|
|
AEBP1
|
AE binding protein 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHCY
|
adenosylhomocysteinase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIMP1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIPL1
|
aryl hydrocarbon receptor interacting protein-like 1
|
|
AIRE
|
autoimmune regulator
|
|
AK2
|
adenylate kinase 2
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKR1D1
|
aldo-keto reductase family 1, member D1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALB
|
albumin
|
|
ALDH3A2
|
aldehyde dehydrogenase 3 family, member A2
|
|
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMELX
|
amelogenin, X-linked
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANO5
|
anoctamin 5
|
|
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
APC
|
adenomatous polyposis coli
|
|
APCS
|
amyloid P component, serum
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOC2
|
apolipoprotein C-II
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
AQP7
|
aquaporin 7
|
|
AR
|
androgen receptor
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
|
ARL6
|
ADP-ribosylation factor-like 6
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB2
|
arrestin, beta 2
|
|
ASH1L
|
ash1 (absent, small, or homeotic)-like (Drosophila)
|
|
ASPA
|
aspartoacylase
|
|
ATF2
|
activating transcription factor 2
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATL1
|
atlastin GTPase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous
|
|
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1
|
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATPIF1
|
ATPase inhibitory factor 1
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
ATXN8OS
|
ATXN8 opposite strand (non-protein coding)
|
|
AURKB
|
aurora kinase B
|
|
AURKC
|
aurora kinase C
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BARX1
|
BARX homeobox 1
|
|
BBS10
|
Bardet-Biedl syndrome 10
|
|
BBS4
|
Bardet-Biedl syndrome 4
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2L1
|
BCL2-like 1
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BHMT
|
betaine--homocysteine S-methyltransferase
|
|
BICD2
|
bicaudal D homolog 2 (Drosophila)
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BOK
|
BCL2-related ovarian killer
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C10ORF2
|
chromosome 10 open reading frame 2
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA8
|
carbonic anhydrase VIII
|
|
CABYR
|
calcium binding tyrosine-(Y)-phosphorylation regulated
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1F
|
calcium channel, voltage-dependent, L type, alpha 1F subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCAR1
|
cell division cycle and apoptosis regulator 1
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD163
|
CD163 molecule
|
|
CD177
|
CD177 molecule
|
|
CD19
|
CD19 molecule
|
|
CD22
|
CD22 molecule
|
|
CD247
|
CD247 molecule
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD52
|
CD52 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK5RAP2
|
CDK5 regulatory subunit associated protein 2
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CENPA
|
centromere protein A
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFHR5
|
complement factor H-related 5
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHGA
|
chromogranin A
|
|
CHM
|
choroideremia (Rab escort protein 1)
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle)
|
|
CHRND
|
cholinergic receptor, nicotinic, delta (muscle)
|
|
CHST6
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
|
|
CKB
|
creatine kinase, brain
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLCN7
|
chloride channel, voltage-sensitive 7
|
|
CLDN5
|
claudin 5
|
|
CLIC4
|
chloride intracellular channel 4
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CMKLR1
|
chemerin chemokine-like receptor 1
|
|
CNBP
|
CCHC-type zinc finger, nucleic acid binding protein
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
CNN2
|
calponin 2
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
COCH
|
cochlin
|
|
COL10A1
|
collagen, type X, alpha 1
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COL8A1
|
collagen, type VIII, alpha 1
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX10
|
COX10 heme A:farnesyltransferase cytochrome c oxidase assembly factor
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPOX
|
coproporphyrinogen oxidase
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CRB2
|
crumbs family member 2
|
|
CREBBP
|
CREB binding protein
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRISP3
|
cysteine-rich secretory protein 3
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYBB1
|
crystallin, beta B1
|
|
CRYBB2
|
crystallin, beta B2
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
|
CSH2
|
chorionic somatomammotropin hormone 2
|
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein)
|
|
CST3
|
cystatin C
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSC
|
cathepsin C
|
|
CTSK
|
cathepsin K
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DARS2
|
aspartyl-tRNA synthetase 2, mitochondrial
|
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein
|
|
DCAF17
|
DDB1 and CUL4 associated factor 17
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCN
|
decorin
|
|
DDX11
|
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFA1B
|
defensin, alpha 1B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEPTOR
|
DEP domain containing MTOR-interacting protein
|
|
DES
|
desmin
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DMD
|
dystrophin
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNAH1
|
dynein, axonemal, heavy chain 1
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
|
DNAJB6
|
DnaJ (Hsp40) homolog, subfamily B, member 6
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNM2
|
dynamin 2
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSC2
|
desmocollin 2
|
|
DSG1
|
desmoglein 1
|
|
DSP
|
desmoplakin
|
|
DSPP
|
dentin sialophosphoprotein
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUOXA1
|
dual oxidase maturation factor 1
|
|
DUSP5
|
dual specificity phosphatase 5
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
DYNC1H1
|
dynein, cytoplasmic 1, heavy chain 1
|
|
DYNC2H1
|
dynein, cytoplasmic 2, heavy chain 1
|
|
DYSF
|
dysferlin
|
|
DYT7
|
dystonia 7, torsion (autosomal dominant)
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDA
|
ectodysplasin A
|
|
EDAR
|
ectodysplasin A receptor
|
|
EDN1
|
endothelin 1
|
|
EDN3
|
endothelin 3
|
|
EDNRB
|
endothelin receptor type B
|
|
EFHC1
|
EF-hand domain (C-terminal) containing 1
|
|
EFNA1
|
ephrin-A1
|
|
EFTUD2
|
elongation factor Tu GTP binding domain containing 2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
EHD3
|
EH-domain containing 3
|
|
EHMT1
|
euchromatic histone-lysine N-methyltransferase 1
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EIF2B1
|
eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa
|
|
EIF2B2
|
eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EMD
|
emerin
|
|
EN2
|
engrailed homeobox 2
|
|
ENAM
|
enamelin
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP7
|
ectonucleotide pyrophosphatase/phosphodiesterase 7
|
|
EP300
|
E1A binding protein p300
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRB
|
estrogen-related receptor beta
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
EVC
|
Ellis van Creveld protein
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EXTL3
|
exostosin-like glycosyltransferase 3
|
|
EYA4
|
EYA transcriptional coactivator and phosphatase 4
|
|
EYS
|
eyes shut homolog (Drosophila)
|
|
EZR
|
ezrin
|
|
F11
|
coagulation factor XI
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAM126A
|
family with sequence similarity 126, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FAT4
|
FAT atypical cadherin 4
|
|
FBLN1
|
fibulin 1
|
|
FBN1
|
fibrillin 1
|
|
FBXO32
|
F-box protein 32
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGB
|
fibrinogen beta chain
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF3
|
fibroblast growth factor 3
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGG
|
fibrinogen gamma chain
|
|
FHL1
|
four and a half LIM domains 1
|
|
FHL2
|
four and a half LIM domains 2
|
|
FKBP5
|
FK506 binding protein 5
|
|
FKRP
|
fukutin related protein
|
|
FLCN
|
folliculin
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FOXE1
|
forkhead box E1
|
|
FOXE3
|
forkhead box E3
|
|
FOXF2
|
forkhead box F2
|
|
FOXG1
|
forkhead box G1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FPGS
|
folylpolyglutamate synthase
|
|
FPR2
|
formyl peptide receptor 2
|
|
FRAS1
|
Fraser extracellular matrix complex subunit 1
|
|
FREM2
|
FRAS1 related extracellular matrix protein 2
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FZD4
|
frizzled class receptor 4
|
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRE
|
gamma-aminobutyric acid (GABA) A receptor, epsilon
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALE
|
UDP-galactose-4-epimerase
|
|
GARS
|
glycyl-tRNA synthetase
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA4
|
GATA binding protein 4
|
|
GATA5
|
GATA binding protein 5
|
|
GBA
|
glucosidase, beta, acid
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF5
|
growth differentiation factor 5
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFM1
|
G elongation factor, mitochondrial 1
|
|
GH1
|
growth hormone 1
|
|
GH2
|
growth hormone 2
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLC1C
|
glaucoma 1, open angle, C
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GLRX
|
glutaredoxin (thioltransferase)
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GNAS
|
GNAS complex locus
|
|
GNAT2
|
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPD1
|
glycerol-3-phosphate dehydrogenase 1 (soluble)
|
|
GPR78
|
G protein-coupled receptor 78
|
|
GPSM2
|
G-protein signaling modulator 2
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRM6
|
glutamate receptor, metabotropic 6
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFX
|
H2A histone family, member X
|
|
HADHA
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS1
|
hyaluronan synthase 1
|
|
HBB
|
hemoglobin, beta
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HEXA
|
hexosaminidase A (alpha polypeptide)
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST1H1A
|
histone cluster 1, H1a
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HOXB4
|
homeobox B4
|
|
HOXB5
|
homeobox B5
|
|
HOXD13
|
homeobox D13
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HPSE
|
heparanase
|
|
HR
|
hair growth associated
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
|
|
IDDM17
|
insulin-dependent diabetes mellitus 17
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDS
|
iduronate 2-sulfatase
|
|
IER3
|
immediate early response 3
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IHH
|
indian hedgehog
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17RA
|
interleukin 17 receptor A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RAPL1
|
interleukin 1 receptor accessory protein-like 1
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL27
|
interleukin 27
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL37
|
interleukin 37
|
|
IL4I1
|
interleukin 4 induced 1
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
ILDR1
|
immunoglobulin-like domain containing receptor 1
|
|
IMPAD1
|
inositol monophosphatase domain containing 1
|
|
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRGM
|
immunity-related GTPase family, M
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JAK2
|
Janus kinase 2
|
|
JPH3
|
junctophilin 3
|
|
JUP
|
junction plakoglobin
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCTD18
|
potassium channel tetramerization domain containing 18
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIAA0196
|
KIAA0196
|
|
KIAA0226
|
KIAA0226
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT1
|
keratin 1, type II
|
|
KRT12
|
keratin 12, type I
|
|
KRT13
|
keratin 13, type I
|
|
KRT14
|
keratin 14, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT23
|
keratin 23, type I
|
|
KRT3
|
keratin 3, type II
|
|
KRT4
|
keratin 4, type II
|
|
KRT5
|
keratin 5, type II
|
|
KRT71
|
keratin 71, type II
|
|
KRT9
|
keratin 9, type I
|
|
KSR1
|
kinase suppressor of ras 1
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMA1
|
laminin, alpha 1
|
|
LAMB2
|
laminin, beta 2 (laminin S)
|
|
LAMTOR2
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIPG
|
lipase, endothelial
|
|
LIPH
|
lipase, member H
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
|
LMBR1
|
limb development membrane protein 1
|
|
LMNA
|
lamin A/C
|
|
LOC647859
|
occludin pseudogene
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPAR6
|
lysophosphatidic acid receptor 6
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
LY96
|
lymphocyte antigen 96
|
|
LZTS1
|
leucine zipper, putative tumor suppressor 1
|
|
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2
|
|
MAK
|
male germ cell-associated kinase
|
|
MAOA
|
monoamine oxidase A
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MASTL
|
microtubule associated serine/threonine kinase-like
|
|
MBP
|
myelin basic protein
|
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2
|
|
MCM3
|
minichromosome maintenance complex component 3
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MEFV
|
Mediterranean fever
|
|
MEGF10
|
multiple EGF-like-domains 10
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MFN1
|
mitofusin 1
|
|
MGLL
|
monoglyceride lipase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIR1206
|
microRNA 1206
|
|
MIR1290
|
microRNA 1290
|
|
MIR134
|
microRNA 134
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR205
|
microRNA 205
|
|
MIR223
|
microRNA 223
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR301A
|
microRNA 301a
|
|
MIR34A
|
microRNA 34a
|
|
MIR375
|
microRNA 375
|
|
MIR487B
|
microRNA 487b
|
|
MIR612
|
microRNA 612
|
|
MIR655
|
microRNA 655
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP20
|
matrix metallopeptidase 20
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MPO
|
myeloperoxidase
|
|
MPV17
|
MpV17 mitochondrial inner membrane protein
|
|
MPZ
|
myelin protein zero
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRPL44
|
mitochondrial ribosomal protein L44
|
|
MRX82
|
mental retardation, X-linked 82
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MSRA
|
methionine sulfoxide reductase A
|
|
MSRB2
|
methionine sulfoxide reductase B2
|
|
MSTN
|
myostatin
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MT-TM
|
tRNA
|
|
MT1A
|
metallothionein 1A
|
|
MTF1
|
metal-regulatory transcription factor 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MUTYH
|
mutY homolog
|
|
MVK
|
mevalonate kinase
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYF5
|
myogenic factor 5
|
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO15A
|
myosin XVA
|
|
MYO5B
|
myosin VB
|
|
MYO7A
|
myosin VIIA
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYP13
|
myopia 13
|
|
NAGK
|
N-acetylglucosamine kinase
|
|
NAGLU
|
N-acetylglucosaminidase, alpha
|
|
NAGS
|
N-acetylglutamate synthase
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFV1
|
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa
|
|
NDUFV3
|
NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLGN3
|
neuroligin 3
|
|
NLGN4X
|
neuroligin 4, X-linked
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRG3
|
neuregulin 3
|
|
NRL
|
neural retina leucine zipper
|
|
NRXN1
|
neurexin 1
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NSDHL
|
NAD(P) dependent steroid dehydrogenase-like
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUB1
|
negative regulator of ubiquitin-like proteins 1
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUP62
|
nucleoporin 62kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
OCA2
|
oculocutaneous albinism II
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
|
|
OPN1LW
|
opsin 1 (cone pigments), long-wave-sensitive
|
|
OPN1MW
|
opsin 1 (cone pigments), medium-wave-sensitive
|
|
OPN4
|
opsin 4
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OSMR
|
oncostatin M receptor
|
|
OTOF
|
otoferlin
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P3H1
|
prolyl 3-hydroxylase 1
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX1
|
paired box 1
|
|
PAX6
|
paired box 6
|
|
PAX9
|
paired box 9
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDE6C
|
phosphodiesterase 6C, cGMP-specific, cone, alpha prime
|
|
PDE8B
|
phosphodiesterase 8B
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDS5B
|
PDS5 cohesin associated factor B
|
|
PDXK
|
pyridoxal (pyridoxine, vitamin B6) kinase
|
|
PER2
|
period circadian clock 2
|
|
PEX14
|
peroxisomal biogenesis factor 14
|
|
PEX16
|
peroxisomal biogenesis factor 16
|
|
PEX6
|
peroxisomal biogenesis factor 6
|
|
PGD
|
phosphogluconate dehydrogenase
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PITX3
|
paired-like homeodomain 3
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKP2
|
plakophilin 2
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLEKHG4
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 4
|
|
PLN
|
phospholamban
|
|
PLP1
|
proteolipid protein 1
|
|
PMP22
|
peripheral myelin protein 22
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
|
PNLIP
|
pancreatic lipase
|
|
PNPLA6
|
patatin-like phospholipase domain containing 6
|
|
POLDIP3
|
polymerase (DNA-directed), delta interacting protein 3
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU4F3
|
POU class 4 homeobox 3
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPFIA1
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRICKLE2
|
prickle homolog 2 (Drosophila)
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRL
|
prolactin
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROKR2
|
prokineticin receptor 2
|
|
PROS1
|
protein S (alpha)
|
|
PRPH
|
peripherin
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PSEN1
|
presenilin 1
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTX3
|
pentraxin 3, long
|
|
PXN
|
paxillin
|
|
PYY
|
peptide YY
|
|
QPCT
|
glutaminyl-peptide cyclotransferase
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RACGAP1
|
Rac GTPase activating protein 1
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RANBP2
|
RAN binding protein 2
|
|
RAPSN
|
receptor-associated protein of the synapse
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RB1
|
retinoblastoma 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBM20
|
RNA binding motif protein 20
|
|
RBM4
|
RNA binding motif protein 4
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCHY1
|
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
|
|
RDH8
|
retinol dehydrogenase 8 (all-trans)
|
|
REEP1
|
receptor accessory protein 1
|
|
RELN
|
reelin
|
|
REM2
|
RAS (RAD and GEM)-like GTP binding 2
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS3
|
regulator of G-protein signaling 3
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOT1
|
ras homolog family member T1
|
|
RHOT2
|
ras homolog family member T2
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RLN2
|
relaxin 2
|
|
RLS4
|
Restless legs syndrome 4
|
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase
|
|
RNR1
|
RNA, ribosomal cluster 1
|
|
RNU4ATAC
|
RNA, U4atac small nuclear (U12-dependent splicing)
|
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila)
|
|
ROGDI
|
rogdi homolog (Drosophila)
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RP1
|
retinitis pigmentosa 1 (autosomal dominant)
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RS1
|
retinoschisin 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A12
|
S100 calcium binding protein A12
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SACK1H
|
scaffolding CK1 anchoring protein H
|
|
SAFB
|
scaffold attachment factor B
|
|
SAFB2
|
scaffold attachment factor B2
|
|
SALL1
|
spalt-like transcription factor 1
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAMD4A
|
sterile alpha motif domain containing 4A
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCA20
|
spinocerebellar ataxia 20
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCLT1
|
sodium channel and clathrin linker 1
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCO2
|
SCO2 cytochrome c oxidase assembly protein
|
|
SDC2
|
syndecan 2
|
|
SDCCAG8
|
serologically defined colon cancer antigen 8
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SEC16A
|
SEC16 homolog A (S. cerevisiae)
|
|
SEC16B
|
SEC16 homolog B (S. cerevisiae)
|
|
SEC62
|
SEC62 homolog (S. cerevisiae)
|
|
SELE
|
selectin E
|
|
SEPW1
|
selenoprotein W, 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETBP1
|
SET binding protein 1
|
|
SETD2
|
SET domain containing 2
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SF1
|
splicing factor 1
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFTPC
|
surfactant protein C
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SGSH
|
N-sulfoglucosamine sulfohydrolase
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SH3GL2
|
SH3-domain GRB2-like 2
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SIL1
|
SIL1 nucleotide exchange factor
|
|
SIRT1
|
sirtuin 1
|
|
SIRT6
|
sirtuin 6
|
|
SIRT7
|
sirtuin 7
|
|
SIX6
|
SIX homeobox 6
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC17A5
|
solute carrier family 17 (acidic sugar transporter), member 5
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A10
|
solute carrier family 2 (facilitated glucose transporter), member 10
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC33A1
|
solute carrier family 33 (acetyl-CoA transporter), member 1
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC46A2
|
solute carrier family 46, member 2
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
|
SLC52A3
|
solute carrier family 52 (riboflavin transporter), member 3
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A19
|
solute carrier family 6 (neutral amino acid transporter), member 19
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A9
|
solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SLITRK1
|
SLIT and NTRK-like family, member 1
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCAIP
|
synuclein, alpha interacting protein
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPAG11B
|
sperm associated antigen 11B
|
|
SPATA16
|
spermatogenesis associated 16
|
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SPN
|
sialophorin
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRCAP
|
Snf2-related CREBBP activator protein
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SRSF5
|
serine/arginine-rich splicing factor 5
|
|
SRSF7
|
serine/arginine-rich splicing factor 7
|
|
SRY
|
sex determining region Y
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR3
|
somatostatin receptor 3
|
|
SSTR5
|
somatostatin receptor 5
|
|
SSX2IP
|
synovial sarcoma, X breakpoint 2 interacting protein
|
|
ST6GALNAC5
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STK11
|
serine/threonine kinase 11
|
|
STK38
|
serine/threonine kinase 38
|
|
STOX1
|
storkhead box 1
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SUCLA2
|
succinate-CoA ligase, ADP-forming, beta subunit
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUMO2
|
small ubiquitin-like modifier 2
|
|
SUMO3
|
small ubiquitin-like modifier 3
|
|
SYN3
|
synapsin III
|
|
SYNGR1
|
synaptogyrin 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBC1D32
|
TBC1 domain family, member 32
|
|
TCERG1
|
transcription elongation regulator 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM6
|
transglutaminase 6
|
|
TH
|
tyrosine hydroxylase
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBS1
|
thrombospondin 1
|
|
THPO
|
thrombopoietin
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR1
|
toll-like receptor 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM126A
|
transmembrane protein 126A
|
|
TMEM134
|
transmembrane protein 134
|
|
TMIE
|
transmembrane inner ear
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TMPRSS3
|
transmembrane protease, serine 3
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNMD
|
tenomodulin
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TNNT3
|
troponin T type 3 (skeletal, fast)
|
|
TOM1L1
|
target of myb1 (chicken)-like 1
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOX
|
thymocyte selection-associated high mobility group box
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TPRN
|
taperin
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TPSB2
|
tryptase beta 2 (gene/pseudogene)
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRD
|
T cell receptor delta locus
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRG
|
T cell receptor gamma locus
|
|
TRH
|
thyrotropin-releasing hormone
|
|
TRIM21
|
tripartite motif containing 21
|
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase
|
|
TRNE
|
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TRRAP
|
transformation/transcription domain-associated protein
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TTC37
|
tetratricopeptide repeat domain 37
|
|
TTR
|
transthyretin
|
|
TUFM
|
Tu translation elongation factor, mitochondrial
|
|
TULP1
|
tubby like protein 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
UBE2N
|
ubiquitin-conjugating enzyme E2N
|
|
UBE2V2
|
ubiquitin-conjugating enzyme E2 variant 2
|
|
UBR1
|
ubiquitin protein ligase E3 component n-recognin 1
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
ULBP2
|
UL16 binding protein 2
|
|
UMOD
|
uromodulin
|
|
UNG
|
uracil-DNA glycosylase
|
|
USB1
|
U6 snRNA biogenesis 1
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VCP
|
valosin containing protein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VSX1
|
visual system homeobox 1
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WDR36
|
WD repeat domain 36
|
|
WDR62
|
WD repeat domain 62
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WT1
|
Wilms tumor 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPO1
|
exportin 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YARS
|
tyrosyl-tRNA synthetase
|
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
|
|
ZBED6
|
zinc finger, BED-type containing 6
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZIC3
|
Zic family member 3
|
|
ZMPSTE24
|
zinc metallopeptidase STE24
|
|
ZNF148
|
zinc finger protein 148
|
|
ZNF214
|
zinc finger protein 214
|
|
ZNF804A
|
zinc finger protein 804A
|
